At Linked In, Xander van Wijk posts a free one-hour webinar on lab-developed LDTs that are also AI.
It's November 5, 9 pacific, 12 eastern. "AI Meets LDT: Navigating the New Frontier of Clinical Diagnostics." A program from ADLM - Innovation & Technology Division.
Register with name and email here:
https://myadlm-org.zoom.us/meeting/register/zL7qD_yiSwGhqAy7krF27Q#/registration
"Join us for an engaging webinar exploring the intersection of artificial intelligence and medical diagnostics. The session will demystify how AI components - especially SaMD - are reshaping laboratory workflow, regulatory oversight, and risk management. Get practical insights into FDA authority, risk calculation strategies, and proactive planning for AI integration.
Whether you're a lab director, compliance officer, or clinical scientist, this webinar will equip you with the tools to navigate this evolving landscape."
I don't know if the video will be archived after the live event, or not.
##
Speakers are Christine P. Bump JD, Penn Avenue Law & Policy, and Shannon Bennet MS MBA Mayo Clinic. See Shannon's comment here.
"FDA may not have oversight of laboratory developed tests (LDTs), but they DO have regulatory oversight of software as a medical device. It's a critically important distinction."
